Parallax Volatility Advisers’s Opko Health OPK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-450,000
Closed -$662K 1983
2024
Q4
$662K Hold
450,000
﹤0.01% 1449
2024
Q3
$671K Buy
+450,000
New +$668K ﹤0.01% 1457
2024
Q1
Sell
-69,500
Closed -$105K 2211
2023
Q4
$105K Buy
+69,500
New +$100K ﹤0.01% 1871
2022
Q1
Sell
-300,000
Closed -$1.44M 3047
2021
Q4
$1.44M Hold
300,000
﹤0.01% 1163
2021
Q3
$1.09M Hold
300,000
﹤0.01% 1319
2021
Q2
$1.22M Hold
300,000
﹤0.01% 972
2021
Q1
$1.29M Sell
300,000
-348,000
-54% -$1.66M ﹤0.01% 779
2020
Q4
$2.56M Sell
648,000
-152,000
-19% -$635K ﹤0.01% 1180
2020
Q3
$2.95M Buy
800,000
+52,500
+7% +$222K ﹤0.01% 1539
2020
Q2
$2.55M Buy
747,500
+247,500
+50% +$554K ﹤0.01% 1376
2020
Q1
$670K Hold
500,000
﹤0.01% 1611
2019
Q4
$735K Hold
500,000
﹤0.01% 1616
2019
Q3
$1.04M Hold
500,000
﹤0.01% 1358
2019
Q2
$1.22M Buy
+500,000
New +$1.09M ﹤0.01% 1211
2016
Q4
Sell
-50,000
Closed -$530K 3797
2016
Q3
$530K Buy
+50,000
New +$498K ﹤0.01% 1481
2015
Q1
Sell
-30,000
Closed -$300K 5151
2014
Q4
$300K Buy
+30,000
New +$257K ﹤0.01% 2482

Other funds holding OPK

Parallax Volatility Advisers's OPK Position: Q3 2024 in Review

Parallax Volatility Advisers sold out of Opko Health (OPK) in Q3 2024, closing a stake of 77,649 shares — an estimated $115K sold.

Parallax Volatility Advisers first reported a position in OPK in Q4 2017 and held it in 16 quarters. The position peaked at $3.72M in Q4 2018. 234 funds tracked by Wall St. Rank hold OPK as of Q3 2024.

  • Parallax Volatility Advisers reported no remaining Opko Health position as of Q3 2024 after selling out during the quarter.
  • Parallax Volatility Advisers sold 77,649 Opko Health shares in Q3 2024, an estimated $115K.
  • Parallax Volatility Advisers first reported a position in Opko Health in Q4 2017 and held it in 16 quarters.
  • Parallax Volatility Advisers's Opko Health position peaked at $3.72M in Q4 2018.
  • 234 funds tracked by Wall St. Rank held Opko Health as of Q3 2024.

Based on Parallax Volatility Advisers's 13F filing for Q3 2024, filed 14 Nov 2024.